Stress Reactivity and Mother-Infant Cardiovascular Disease Risk (NCT06805799)
Maternal-Infant Stress Reactivity as an Intergenerational Pathway to Cardiovascular Disease Risk
๐ฉบ Plain-English Summary (8th-Grade Level)
Prenatal Mindfulness training (MT) shows promise as a preventive intervention against hypertensive disorders of pregnancy (HDP) and may reduce risk for offspring cardiovascular disease (CVD). One proposed mechanism of MT to reduced CVD risk is improved self-regulation following stress. Perhaps the most crucial contributor to the development of self-regulation in the first year is the psychophysiological coregulatory relationship between mother and infant. However, this self-and co-regulation among women exposed to prenatal MT has not been studied and has yet to be examined in relation to CVD risk. The goal of this proposed project is to evaluate maternal-infant physiological reactivity to and recovery from stress at 6 months postpartum following prenatal MT, and to examine the relationship between these maternal infant stress responses and maternal-infant CVD risk at 12 months postpartum. Using a lab-based stress paradigm and well-validated biomarkers of mother and infant CVD risk, the investigators will assess respiratory sinus arrhythmia and heart rate at 6 months postpartum for 40 mother-infant dyads who have completed either prenatal MT or a usual care arm of an RCT examining MT for women at risk for HDP. The investigators will compare maternal, infant, and dyadic stress responses by treatment arm. Then, cardiac stress responses will be examined as predictors of maternal and infant biomarkers of CVD risk at 12 months postpartum.
Who can join: Review the eligibility criteria below.
Location: Women's Medicine Collaborative, Lifespan โ Providence, Rhode Island
Age range: 6 Months
๐งช Interventions in This Study
- Follow up to Mindfulness RCT using a Still Face Paradigm (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Women's Medicine Collaborative, Lifespan โ Providence, Rhode Island
๐ Contact the Study Coordinator
Phone: (401) 606-3000
Email: micheline_anderson@brown.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Maternal Health
- Understanding the Role of Doulas in Supporting People With PMADs โ Missoula, Montana
- Telehealth Multi-Component Optional Model (MOM) Study โ El Dorado, Arkansas
- Boston Birth Cohort Study โ Boston, Massachusetts
Explore by condition: All Maternal Health clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.